T14 · Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class S
2.75
USDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
US$3.69B
PE
8.90
EV/EBITDA
14
DIV Yield
19.5%
Payout Ratio
173%
MQV Rating
5Very Weak
As at 24/07/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- HALO 200
- HALO All
- HALO Small
- Near Support
Key Fundamentals
EPS 3 yr Growth
131.20%
EBITDA Margin
21.40%
Operating Cashflow
$69m
Free Cash Flow Return
6.60%
ROIC
28.30%
Interest Coverage
55.40
Quick Ratio
1.30
Performance
52 weeks range
Low 2.48 - 3.75
Trade Value (12mth)
US$151,101.00
1 week
-1.43%
1 month
-8.33%
YTD
-17.42%
1 year
6.59%
All time high
3.75
Additional Data
Shares Outstanding (Fully Diluted)
770m
HALO Sector
Healthcare
Next Company Report Date
29-Mar-27
Next Ex Dividend Date
29-Jun-26
Next Dividend Pay Date
10-Jul-26
Reporting Currency
USD
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Very Weak
Momentum
Price
Very Weak
Earnings
Very Weak
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
News & Announcements
No announcements available.
